It’s raining resignations_Part 2
This time it’s
an Aurobindo CEO. Drug firm Aurobindo Pharma said its Chief Executive Officer
(Formulations) Arvind Vasudeva has resigned from the company.
Recently,
the drug firm had said that it intends to invest up to Rs 900 crore this fiscal
on various activities including capacity expansion, clinical trials and product
filings.
The company
has presence in semi-synthetic penicillins and other key therapeutic segments
such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics,
gastroenterology and cephalosporins among others.
Comments
Post a Comment